Unfortunately, it can take years for some of the SAEs caused by a mutagenic drug to manifest. Expect a significant increase in cancer over the long term. I suspect that this delay in the appearance of cancer SAEs is what Merck is counting on. Also, if they get the drug approved under an EUA, their liability is very limited. That leaves their suffering victim’s health AND finances in the toilet. Any system that allows this to happen is a failed system.
HereToday said,
So my guess is that Molnupiravir will see less than 50% effective once all said and done along with a bunch of really bad SAE’s to boot!!!
Merck's pill failed to help hospitalized patients. B would be needed in all hospitalized sick patients where the virus fails to respond because of lacking good treatment. Pneumonia is a big problem in hospitalized people.